Published in J Neurosci on February 01, 2001
Social approach in genetically engineered mouse lines relevant to autism. Genes Brain Behav (2008) 1.94
Serotonin, genetic variability, behaviour, and psychiatric disorders--a review. Ups J Med Sci (2010) 1.67
How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. Neuropharmacology (2008) 1.56
Neural activity: sculptor of 'barrels' in the neocortex. Trends Neurosci (2001) 1.49
Pet-1 is required across different stages of life to regulate serotonergic function. Nat Neurosci (2010) 1.48
Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci U S A (2012) 1.48
Development and critical period plasticity of the barrel cortex. Eur J Neurosci (2012) 1.47
Gene-environment interaction and the genetics of depression. J Psychiatry Neurosci (2004) 1.46
Haploinsufficiency for Pten and Serotonin transporter cooperatively influences brain size and social behavior. Proc Natl Acad Sci U S A (2009) 1.30
Exuberant thalamocortical axon arborization in cortex-specific NMDAR1 knockout mice. J Comp Neurol (2005) 1.21
Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain. Neuroscience (2011) 1.18
Serotonin and prefrontal cortex function: neurons, networks, and circuits. Mol Neurobiol (2011) 1.17
Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments. Neuropsychopharmacology (2011) 1.15
Perinatal antidepressant exposure alters cortical network function in rodents. Proc Natl Acad Sci U S A (2011) 1.12
Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice. Proc Natl Acad Sci U S A (2005) 1.08
Is fetal brain monoamine oxidase inhibition the missing link between maternal smoking and conduct disorders? J Psychiatry Neurosci (2008) 1.03
Genetic animal models of anxiety. Neurogenetics (2003) 1.00
The serotonin system in autism spectrum disorder: From biomarker to animal models. Neuroscience (2015) 0.99
Monoamine oxidase A and A/B knockout mice display autistic-like features. Int J Neuropsychopharmacol (2012) 0.97
mGluR5 in cortical excitatory neurons exerts both cell-autonomous and -nonautonomous influences on cortical somatosensory circuit formation. J Neurosci (2010) 0.96
Ontogeny and regulation of the serotonin transporter: providing insights into human disorders. Pharmacol Ther (2011) 0.96
Neurotransmitter release at the thalamocortical synapse instructs barrel formation but not axon patterning in the somatosensory cortex. J Neurosci (2012) 0.95
Zic2 regulates the expression of Sert to modulate eye-specific refinement at the visual targets. EMBO J (2010) 0.95
Early pharmacological treatment of autism: a rationale for developmental treatment. Biol Psychiatry (2007) 0.95
Postnatal growth defects in mice with constitutive depletion of central serotonin. ACS Chem Neurosci (2012) 0.95
A pharmacological analysis of mice with a targeted disruption of the serotonin transporter. Psychopharmacology (Berl) (2007) 0.94
Social deficits and perseverative behaviors, but not overt aggression, in MAO-A hypomorphic mice. Neuropsychopharmacology (2011) 0.94
Group II metabotropic glutamate receptors inhibit glutamate release at thalamocortical synapses in the developing somatosensory cortex. Neuroscience (2007) 0.94
Neonatal serotonin depletion alters behavioral responses to spatial change and novelty. Brain Res (2007) 0.94
Monoamine-sensitive developmental periods impacting adult emotional and cognitive behaviors. Neuropsychopharmacology (2014) 0.93
What can we get from 'barrels': the rodent barrel cortex as a model for studying the establishment of neural circuits. Eur J Neurosci (2011) 0.93
Serotonin homeostasis and serotonin receptors as actors of cortical construction: special attention to the 5-HT3A and 5-HT6 receptor subtypes. Front Cell Neurosci (2013) 0.91
Insights into the complex influence of 5-HT signaling on thalamocortical axonal system development. Eur J Neurosci (2012) 0.90
Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. Int Rev Neurobiol (2011) 0.90
Connecting the retina to the brain. ASN Neuro (2014) 0.90
Maladaptive defensive behaviours in monoamine oxidase A-deficient mice. Int J Neuropsychopharmacol (2010) 0.89
Serotonergic facilitation of synaptic activity in the developing rat prefrontal cortex. J Physiol (2004) 0.88
Chronic 5-HT transporter blockade reduces DA signaling to elicit basal ganglia dysfunction. J Neurosci (2011) 0.86
Developmental effects of SSRIs: lessons learned from animal studies. Int J Dev Neurosci (2007) 0.86
Differential gene expression in the developing lateral geniculate nucleus and medial geniculate nucleus reveals novel roles for Zic4 and Foxp2 in visual and auditory pathway development. J Neurosci (2009) 0.85
High serotonin levels during brain development alter the structural input-output connectivity of neural networks in the rat somatosensory layer IV. Front Cell Neurosci (2013) 0.85
Lhx2 regulates a cortex-specific mechanism for barrel formation. Proc Natl Acad Sci U S A (2013) 0.85
Adult neurogenesis in serotonin transporter deficient mice. J Neural Transm (Vienna) (2007) 0.84
Developmental changes in serotonin signaling: Implications for early brain function, behavior and adaptation. Neuroscience (2016) 0.82
Serotonin-related pathways and developmental plasticity: relevance for psychiatric disorders. Dialogues Clin Neurosci (2014) 0.81
Marked decrease of LSD-induced stimulus control in serotonin transporter knockout mice. Pharmacol Biochem Behav (2007) 0.81
Refining the Role of 5-HT in Postnatal Development of Brain Circuits. Front Cell Neurosci (2017) 0.80
Early postnatal inhibition of serotonin synthesis results in long-term reductions of perseverative behaviors, but not aggression, in MAO A-deficient mice. Neuropharmacology (2013) 0.79
Genetic Variation in Serotonin Transporter Modulates Tactile Hyperresponsiveness in ASD. Res Autism Spectr Disord (2015) 0.79
Mapping functional brain activation using [14C]-iodoantipyrine in male serotonin transporter knockout mice. PLoS One (2011) 0.79
Biochemical, behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A or B. Brain Res Bull (2001) 0.78
At diabetes-like concentration, glucose down-regulates the placental serotonin transport system in a cell-cycle-dependent manner. J Neurochem (2007) 0.77
Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression. J Neural Transm (Vienna) (2015) 0.77
Lasting neurobehavioral abnormalities in rats after neonatal activation of serotonin 1A and 1B receptors: possible mechanisms for serotonin dysfunction in autistic spectrum disorders. Psychopharmacology (Berl) (2013) 0.77
Developmental decline in modulation of glutamatergic synapses in layer IV of the barrel cortex by group II metabotropic glutamate receptors. Neuroscience (2015) 0.77
Serotonin receptor 6 mediates defective brain development in monoamine oxidase A-deficient mouse embryos. J Biol Chem (2014) 0.76
Trio-based exome sequencing arrests de novo mutations in early-onset high myopia. Proc Natl Acad Sci U S A (2017) 0.75
An autism-associated serotonin transporter variant disrupts multisensory processing. Transl Psychiatry (2017) 0.75
Reduced Inhibition within Layer IV of Sert Knockout Rat Barrel Cortex is Associated with Faster Sensory Integration. Cereb Cortex (2017) 0.75
Study of the serotonin transporter (SLC6A4) and BDNF genes in French patients with non syndromic mental deficiency. BMC Med Genet (2010) 0.75
Thalamocortical dysconnectivity in autism spectrum disorder: An analysis of the Autism Brain Imaging Data Exchange. Biol Psychiatry Cogn Neurosci Neuroimaging (2017) 0.75
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (1996) 16.04
The SV40 72 base repair repeat has a striking effect on gene expression both in SV40 and other chimeric recombinants. Nucleic Acids Res (1981) 15.12
Adenovirus-2 E1A products repress enhancer-induced stimulation of transcription. Nature (1985) 7.14
Allelic variation of human serotonin transporter gene expression. J Neurochem (1996) 7.08
Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell (2000) 6.45
The genome of human papovavirus BKV. Cell (1979) 6.36
BKV splice sequences based on analysis of preferred donor and acceptor sites. Nucleic Acids Res (1979) 4.86
Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science (1995) 4.59
Organization and sequence studies of the 17-piece chicken conalbumin gene. Nature (1979) 4.36
Sequences upstream from the T-A-T-A box are required in vivo and in vitro for efficient transcription from the adenovirus serotype 2 major late promoter. Proc Natl Acad Sci U S A (1982) 4.30
Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiatry (2006) 3.73
Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease. Lancet (1989) 3.69
Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J (2001) 3.22
An enhancer element is located 340 base pairs upstream from the adenovirus-2 E1A capsite. Nucleic Acids Res (1983) 3.11
Pharmacogenetic prediction of clozapine response. Lancet (2000) 3.10
Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J Virol (1985) 3.06
A common function for polyoma virus large-T and papillomavirus E1 proteins? Nature (1984) 2.96
Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem (1986) 2.95
Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol (1998) 2.94
Early experience and serotonin transporter gene variation interact to influence primate CNS function. Mol Psychiatry (2002) 2.85
Repression of the immunoglobulin heavy chain enhancer by the adenovirus-2 E1A products. Science (1985) 2.81
A rapid enzymatic DNA sequencing technique: determination of sequence alterations in early simian virus 40 temperature sensitive and deletion mutants. Nucleic Acids Res (1980) 2.65
Serotonin transporter gene polymorphism, differential early rearing, and behavior in rhesus monkey neonates. Mol Psychiatry (2002) 2.65
A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry (1996) 2.60
Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest (2001) 2.59
Protein kinase C enhances exocytosis from chromaffin cells by increasing the size of the readily releasable pool of secretory granules. Neuron (1996) 2.59
Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci U S A (1998) 2.54
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc Natl Acad Sci U S A (2001) 2.46
International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev (1996) 2.43
Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J Neurosci (2007) 2.33
Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science (1994) 2.32
Stimulation of in vitro transcription by the upstream element of the adenovirus-2 major late promoter involves a specific factor. Nucleic Acids Res (1984) 2.31
A missense mutation in a novel gene encoding a putative cation channel is associated with catatonic schizophrenia in a large pedigree. Mol Psychiatry (2001) 2.27
Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci U S A (1998) 2.22
Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters. J Neurosci (2001) 2.19
Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc Natl Acad Sci U S A (2001) 2.19
Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nat Genet (1996) 2.18
Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet (1999) 2.16
Localization of 5-HT(6) receptors at the plasma membrane of neuronal cilia in the rat brain. Brain Res (2000) 2.13
Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry (2003) 2.12
Antidepressants recruit new neurons to improve stress response regulation. Mol Psychiatry (2011) 2.11
The human G-protein beta3 subunit C825T polymorphism is associated with coronary artery vasoconstriction. Eur Heart J (2001) 2.08
The challenges of conducting clinical research: one research team's experiences. Clin Nurse Spec (2001) 2.05
Somatodendritic localization of 5-HT1A and preterminal axonal localization of 5-HT1B serotonin receptors in adult rat brain. J Comp Neurol (2000) 2.03
Exclusion of the neuronal nicotinic acetylcholine receptor alpha7 subunit gene as a candidate for catatonic schizophrenia in a large family supporting the chromosome 15q13-22 locus. Mol Psychiatry (2002) 2.01
Neurotransmitter transporters in the central nervous system. Pharmacol Rev (1999) 1.98
Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet (1999) 1.98
Organization of the human serotonin transporter gene. J Neural Transm Gen Sect (1994) 1.97
Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron (1996) 1.96
Social approach in genetically engineered mouse lines relevant to autism. Genes Brain Behav (2008) 1.94
A mutated polyoma virus enhancer which is active in undifferentiated embryonal carcinoma cells is not repressed by adenovirus-2 E1A products. Nature (1986) 1.93
Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem (1993) 1.93
Paranodin, a glycoprotein of neuronal paranodal membranes. Neuron (1997) 1.92
The utility of the non-human primate; model for studying gene by environment interactions in behavioral research. Genes Brain Behav (2003) 1.91
Cellular retinol-binding protein I is essential for vitamin A homeostasis. EMBO J (1999) 1.90
Identification and characterization of a lysosomal transporter for small neutral amino acids. Proc Natl Acad Sci U S A (2001) 1.88
Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor. Nature (1998) 1.88
Platelet 5-HT uptake and release stopped rapidly by formaldehyde. Nature (1975) 1.84
Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice. Circulation (2005) 1.84
Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest (2000) 1.80
Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res (1996) 1.74
International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev (1999) 1.74
A genetic association for cigarette smoking behavior. Health Psychol (1999) 1.69
Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav Immun (1998) 1.69
Transient uptake and storage of serotonin in developing thalamic neurons. Neuron (1996) 1.67
Nucleotide sequence of the BK virus DNA segment encoding small t antigen. Proc Natl Acad Sci U S A (1979) 1.67
Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature (1983) 1.66
Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends Neurosci (1991) 1.65
Human Usher 1B/mouse shaker-1: the retinal phenotype discrepancy explained by the presence/absence of myosin VIIA in the photoreceptor cells. Hum Mol Genet (1996) 1.59
A double blind, randomised, controlled trial of glutamine supplementation in parenteral nutrition. Gut (1999) 1.58
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
Glial cell line-derived neurotrophic factor induces histologic and functional protection of rod photoreceptors in the rd/rd mouse. Invest Ophthalmol Vis Sci (1999) 1.57
Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder. Arch Gen Psychiatry (1987) 1.56
Exploring the genetic link between RLS and ADHD. J Psychiatr Res (2009) 1.55
D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stenting. Circulation (1997) 1.55
Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav (2003) 1.54
Retinitis pigmentosa: rod photoreceptor rescue by a calcium-channel blocker in the rd mouse. Nat Med (1999) 1.49
Transient developmental expression of monoamine transporters in the rodent forebrain. J Comp Neurol (1998) 1.48
Localization of VGLUT3, the vesicular glutamate transporter type 3, in the rat brain. Neuroscience (2004) 1.47
Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences. J Neurosci (2000) 1.46
Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results. Arch Gen Psychiatry (1990) 1.46
A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP. Biol Psychiatry (1993) 1.44
Cloning and characterization of a Drosophila tyramine receptor. EMBO J (1990) 1.42
What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression. Behav Brain Res (2007) 1.41
Restenosis after coronary angioplasty for rapidly progressive coronary stenosis. Eur Heart J (1996) 1.41
Far upstream sequences are required for efficient transcription from the adenovirus-2 E1A transcription unit. Nucleic Acids Res (1983) 1.40
Morphological changes after percutaneous transluminal coronary angioplasty of unstable plaques. Insights from serial angioscopic follow-up. Eur Heart J (1996) 1.40
The human serotonin transporter gene polymorphism--basic research and clinical implications. J Neural Transm (Vienna) (1997) 1.39